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Important gender-based innovations in the prevention of
HIV and other STDs include the introduction of the female
condom and promoting its use in interventions that target
couples.1 In the face of soaring heterosexually acquired HIV
infection globally, the female condom has emerged as an
acceptable alternative or supplemental barrier method to
the male condom.2 The preventive effectiveness of the fe-
male condom against STDs appears comparable to that of
the male condom,3 few (if any) adverse reactions have been
reported among women who have tried the product and
use of the device lowers the risk of bacterial and viral in-
fections.4
In the United States, HIV prevention intervention trials
introducing the female condom have demonstrated in-
creases in reported use among a range of populations: urban
women attending family planning clinics, women attend-
ing STD clinics, women in methadone maintenance treat-
ment and women exchanging sex for drugs or money.5 To
date, however, no studies using a randomized clinical trial
design have either tested the efficacy of a relationship-based
intervention on the use of the female condom among
women and their long-term male sexual partners or com-
pared two strategies for introducing the device. Previous
research has demonstrated promise in increasing female
condom use within stable partnerships,6 and some evidence
suggests that HIV prevention interventions designed to as-
sist women in engaging their male sexual partners in fe-
male condom use may be particularly effective.7 More re-
search is needed on whether involvement of male partners
in the introduction of the device leads to increased use.8
The purpose of this article is to examine female condom
use outcomes among 217 women and their main male sex-
ual partners (434 male and female participants) during a
three-month follow-up period in Project Connect, a ran-
domized clinical trial of a six-session relationship-based
HIV/STD prevention intervention. The principal outcome
in the parent study9 was reduction in unprotected vaginal
intercourse (including both male and female condom use),
assessed three and 12 months postintervention. The main
finding was that relative to participants in the control group,
women and men assigned to the six-session intervention were
more likely to report a reduction in the number of episodes
of unprotected vaginal intercourse. No significant differences
were observed according to whether couples received the
intervention together or the woman received it alone. 
In the present study, the four outcomes on which we
focus are any female condom use, number of female con-
doms used, female condom use intentions and female con-
dom use outcome expectancies (defined as beliefs about
the likelihood of positive or negative outcomes occurring
as a result of engaging in female condom use). Outcomes
are examined with regard to the participant’s study part-
ner alone and all sexual partners. We addressed two re-
search questions: Did the active intervention (whether pro-
vided to the couple together or the woman only) promote
significantly greater improvements in outcomes than the
Promoting Female Condom Use to Heterosexual Couples:
Findings from a Randomized Clinical Trial
Susan S. Witte is asso-
ciate director, Nabila
El-Bassel is director,
Louisa Gilbert is co-
director, Elwin Wu is
assistant director and
Mingway Chang is





York. Jennifer Hill is
assistant professor,
School of Internation-
al and Public Affairs,
Columbia University.
CONTEXT: The female condom remains the only female-initiated method for preventing pregnancy and STDs, includ-
ing HIV. Innovative methods for promoting its use, and for involving male partners in its use, are needed. 
METHODS: A sample of 217 women and their main male sexual partners were randomly assigned to one of three study
conditions: a six-session relationship-based STD prevention intervention provided to the couple together, the same in-
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or took on a woman’s role as she played her partner’s role,
thus creating opportunities for her to practice. Sessions cen-
tered on the woman and her recruited partner, with a strong
emphasis on the relationship, including how issues like in-
timacy, closeness, monogamy and trust can act as barriers
to condom use. The intervention emphasized the impor-
tance of communication, negotiation and problem-solving
skills, and highlighted how relationship dynamics may be
affected by gender roles and expectations. 
Use of the female condom was introduced in the fourth
session, along with a review of male and female anatomy
and an introduction to male condom use skills. All partic-
ipants were shown a brief video on female condom appli-
cation, and then a live demonstration of correct placement
on a pelvic model. In the couples sessions, both the woman
and her partner practiced proper insertion and removal of
the device on a pelvic model; in the women-only sessions,
women practiced on the pelvic model and had the oppor-
tunity to role-play introducing the device and its use to their
partner, played by the facilitator. The advantages and dis-
advantages of the device from both male and female per-
spectives were presented and discussed. Many participants
set a goal to use the female condom with their main part-
ner between the fourth and fifth intervention sessions. Each
participant received three female condoms at the end of
every session. Thus, depending on the number of attend-
ed sessions, participants could receive between zero and
18 female condoms.*
The single STD education control session lasted one hour
and was provided immediately following randomization.
Participants were shown a videotape (available in English
and Spanish),13 which included a discussion and demon-
stration of female condom use, that was followed by a brief
question-and-answer period. Participants did not receive
female condoms, but received information from both the
videotape and the facilitator about where they could pur-
chase the device (at a local pharmacy) or how to obtain it
for free (from New York City Department of Health STD
clinics, from the obstetrics-gynecology clinic within the
study setting or by getting a fiscal order from their physi-
cian or nurse practitioner, to be reimbursed by Medicaid). 
Measures
Baseline and three-month follow-up interviews included
questions on social and demographic characteristics, STD
sexual risk behaviors, HIV status and outcomes of interest.
Participants were asked to report, for study partners and ca-
sual partners, whether a female condom was used during
an act of vaginal intercourse, the number of acts of vaginal
intercourse protected by female condoms (continuous) in
the past 90 days and whether they intended to use the fe-
male condom in the next 90 days. The interview also in-
cluded 18 items from a scale assessing three categories of
female condom use outcome expectancies: physical, social
control intervention? And did providing the intervention
to couples together promote significantly greater im-
provements in outcomes than providing it to women alone? 
METHODS
Study Design
The design of Project Connect, conducted between 1997
and 2001, is described fully elsewhere,10 but summarized
briefly here. All elements of the study protocol were reviewed
and approved annually by the institutional review boards
at the study site and research institution.
Women were recruited from an outpatient clinic facili-
ty at a New York hospital providing a range of primary health
care and social services. A woman was eligible for Project
Connect if she was 18–55 years old; had a male sexual part-
ner whom she identified as a boyfriend, spouse or lover;
was in a long-term relationship (i.e., had been involved with
this partner for the past six months and intended to stay
with him for at least one year); had had at least one episode
of unprotected vaginal or anal sex with this partner in the
past 30 days; did not report any life-threatening abuse by
this partner within the past six months (according to se-
lected questions from the Revised Conflict Tactics Scales);11
and was a patient at any of the hospital’s outpatient clin-
ics. To be eligible, a woman also had to know or suspect
that her partner met at least one of the following STD risk
criteria: He had had sex with other men or women in the
past 90 days, he had had an STD diagnosed or exhibited
symptoms of an STD in the past 90 days, he had injected
drugs in the past 90 days or he was HIV-positive. Of the
388 screened women who were eligible for the study, 217
(56%) successfully recruited their regular male sexual part-
ners and were included in the study.12
Prior to the baseline interview, all participants provided
informed consent. Couples completed face-to-face base-
line assessment interviews simultaneously but separately,
with gender-matched interviewers. They were then ran-
domly assigned to one of three study groups. In the first
group, both the woman and her partner attended six week-
ly relationship-based sessions (N=81 couples). In the sec-
ond, only the woman attended the six weekly sessions
(N=73 couples). In the third, which served as the control
group, only the woman attended one STD information ses-
sion (N=63 couples). The group sizes differed because dur-
ing a regular review of scientific integrity, we determined
that a few random assignment envelopes had been omit-
ted accidentally. We controlled for the effect of across-group
differences, a potential result of this imbalance, in the analy-
ses. All women and men were asked to return for a follow-
up assessment three months postintervention. 
Step-by-step details for the Project Connect intervention
sessions were provided in manuals that guided facilitators
in what to say and what to do as they completed each ses-
sion activity. In the couples sessions, the facilitator provided
coaching and feedback, and encouraged couples to role-
play and engage with each other. In the women-only ses-
sions, the facilitator played the role of a woman’s partner,
*Participants assigned to the six education sessions were also given male
condoms at the end of every session.
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and self-evaluative. Items in the physical category included
“I am comfortable using the female condom” and “I believe
that I can make female condom use fun and erotic”; in the
social category, “I am embarrassed to ask my partner to use
the female condom” and “I encourage my friends to use the
female condom”; and in the self-evaluative category, “the fe-
male condom gives me more personal control over birth con-
trol” and “the female condom gives me more options for pro-
tection.” Each item was scored on a Likert scale from 1
(strongly disagree) to 5 (strongly agree); the final measure
was the sum of the 18 scores (possible range, 18–90, with
higher scores indicating stronger endorsement of positive
outcome expectancies of female condom use). The measure
has an internal consistency reliability of 0.80.14 Interview
staff used a 90-day calendar to help participants recall events
during this time frame. 
Analysis
We used an intention-to-treat approach to estimate treat-
ment effects. This approach requires that all participants
be included in the analyses, including those who did not
complete sessions or follow-up assessments. The follow-
up rates for the couples, women-only and control  groups
were 86%, 84% and 79%, respectively. In the couples group,
the overall session completion rate was 54%; in the women-
only group, 64%. At session four, in which the female con-
dom was introduced, 59% and 71% of the participants as-
signed to the couples and women-only groups attended.
In t tests of bivariate association, attendance in the two ac-
tive intervention groups was not determined to be signifi-
cantly different. Levels of missing outcome data vary by
group and outcome, ranging from 14% (on number of sex-
ual partners for participants in the couples group) to 22%
(on number of unprotected acts for participants in the con-
trol group). 
In chi-square tests of association, several differences at
baseline were found between those who were available for
follow-up and those who were not. For participants assigned
to the control group, women available for follow-up were
less likely to be employed, more likely to have made more
than $5,000 in the last year and more likely to have used
noninjection drugs in the prior 90 days than women not
available for follow-up; they also had fewer instances of un-
protected sex. Men available for follow-up; reported fewer
instances of unprotected sex than men unavailable for 
follow-up; they  In the women-only group, participants who
provided follow-up data were less likely to have complet-
ed high school or have a GED than women not available
for follow-up. These differences argue against using a com-
plete case approach to the missing outcome data because
it requires the assumption that no such differences exist.
We employed multiple imputation15 to handle missing val-
ues; the imputation procedure was performed using Stata
9.0 with a user-written program.16
We conducted t tests to examine the difference in means
among the primary outcomes. We used contrast coding to
examine whether the effects of the two active interventions
differ from those of the control intervention, and whether
the effects of the two active interventions differ from each
other. Contrast coding involves combining variables into
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TABLE 1. Percentage of participants in a trial of a female condom promotion inter-
vention, by selected baseline characteristics, according to gender and intervention
group, New York City, 1997–2001
Characteristic Female Male
Couples Women- Control Couples Women- Control†
(N=81) only (N=63) (N=81) only† (N=63)
(N=73) (N=73)
Age <25 years 9.9 8.2 9.5 7.4 9.6 7.9
Black 54.3 54.8 54.0 48.1 61.6 55.6
Hispanic 38.3 43.8 36.5 42.0 31.5 39.7
High school/GED 42.0 37.0 55.6 44.4 61.1 54.0
Never-married 67.9 57.5 52.4 56.8 54.8 54.0
Employed 11.1 15.1 17.5 24.7* 45.2* 34.9*
Annual income
<$5,000 64.2 72.6 68.3 56.3 46.6 47.6
>1 partner‡ 24.7 23.3 14.3 13.6 16.4 12.7
Ever tested for HIV 95.1 91.8 92.1 92.6 80.8 90.5
HIV-positive 25.9 21.9 15.9 29.6* 16.4* 11.1*
HIV status unknown 6.2 11.0 7.9 8.6* 19.2* 9.5*
No condom use‡ 64.2 71.2 76.2 69.1 69.9 79.4
Used noninjection
drugs‡ 60.8 63.8 44.6 59.2 67.1 63.9
Used injection drugs‡ 11.1 5.5 6.3 12.5 5.5 4.8
Ever had STD 69.1* 60.3* 47.6* 56.8 60.3 49.2
Had STD symptom‡ 50.6 57.5 42.9 11.1 2.7 11.1
Couple HIV status
Both HIV-negative 51.9 49.3 61.9 na na na
Both HIV-positive 19.8 12.3 4.8 na na na
HIV-discordant 14.8 12.3 17.5 na na na
Unknown 13.6 26.0 15.9 na na na
*Differences across groups are significant at p<.05. †Percentages are for the male partners of the women in this
group. ‡In past 90 days. Notes: Calculations are based on the complete data; a few variables are missing data for
up to 6% of participants. na=not applicable.
TABLE 2. Female condom use outcomes reported at baseline and three-month follow-up, by intervention group
Outcome Couples Women-only Control
(N=162) (N=146) (N=126)
Baseline Follow-up Baseline Follow-up Baseline Follow-up
% ever used in past 90 days
With study partner 2.47  (1.22) 22.59* (3.38) 5.62(1.94) 25.48* (3.82) 3.97 (1.75) 11.59 (2.97)
With all partners 3.09 (1.36) 23.21 (3.55) 7.67 (2.24) 27.12* (3.86) 3.97 (1.75) 13.49 (3.12)
Mean no. of uses in past 90 days
With study partner 0.04 (0.02) 0.69 (0.18) 0.10 (0.04) 0.96* (0.29) 0.06 (0.03) 0.30 (0.10)
With all partners 0.06 (0.03) 0.72 (0.18) 0.15 (0.05) 1.10* (0.33) 0.06 (0.03) 0.33 (0.10)
% intending to use in next 90 days 30.86 (3.64) 43.58* (3.98) 35.62 (3.98) 42.88* (4.55) 26.19 (3.93) 27.46 (4.98)
Mean outcome expectancies† 59.43* (0.63) 60.75* (0.80) 57.93 (0.68) 59.49 (0.86) 56.96 (0.75) 57.74 (0.83)
*Significantly different from control group at p≤.05. †Possible range for outcome expectancies is 18–90; the higher the score, the more positive the outcome ex-
pectancy. Note: Figures in parentheses are standard errors. 
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follow-up. In addition, gender and HIV status were included
because they are associated with differential outcomes for
HIV prevention interventions.20 All estimates were obtained
using Stata version 9.0.
RESULTS
Participants across the three study groups were similar on
demographic characteristics and HIV risk behavior (Table
1). The majority of the women and their partners were more
than 25 years old. The majority of participants were black,
and most of the rest were Hispanic; more than half were
never-married.  Roughly 40–60% of participants across all
study groups had at least a high school level of education;
fewer than half were employed, and more than half had low
income levels. A higher proportion of women than of men
reported having multiple sexual partners within the prior
90 days. The high prevalences of reporting a lifetime his-
tory of STD and no condom use in the past 90 days indi-
cate that these couples engaged in HIV risk behaviors. The
only significant differences are for employment and HIV
status among men, and for STD experience among women.
The sample included HIV-negative, HIV-positive and HIV-
discordant couples. 
At the bivariate level, participants in both active inter-
ventions had significantly higher rates of ever-use of the fe-
male condom during follow-up and significantly greater in-
tentions to use it in the next 90 days than did those in the
control group (Table 2). Compared with women in the con-
trol group, participants in the couples group also reported
greater outcome expectancies, and participants in the
women-only group reported more uses of the female con-
dom during follow-up. Patterns of female condom use with
a study partner were consistent with reported use with all
partners. Participants in the women-only group reported a
higher average number and rate of female condom use dur-
subsets for the purpose of direct comparison. Numerically,
the sum of the codes must equal zero. Two contrast codes
were created. First, to test whether the six-session active in-
tervention (delivered either to couples or to women only)
was efficacious compared with one education session, we
numerically weighted the two treatment groups so that their
additive value plus the value given the control group equaled
zero: one-third, one-third and negative two-thirds, respec-
tively. Second, to test whether the intervention was more
efficacious when the woman and her partner received it to-
gether or when the woman received it alone, we coded the
couples, women-only and education control groups one-
half, negative one-half and zero, respectively.
Quantitative estimates of treatment effects relied on or-
dinary least squares regression for female condom use out-
come expectancies, logistic regression for female condoms
use in the past 90 days and intention to use female condoms,
and negative binomial regression for the number of female
condoms used during vaginal intercourse in the past 90
days.17 The unit of analysis was the individual; however,
because reports from partners constituting a couple were
not independent of each other, and would be highly cor-
related, random-effects estimates,18 which accommodate
within-group correlation structures, were used. In this case,
the random effects were incorporated into the ordinary least
squares, logistic and negative binomial regression models,
which allow responses within a couple to be correlated but
assume independence across couples. Further, inclusion
of theoretically important variables related to HIV risk be-
havior in regression models can result in estimates of treat-
ment effects with smaller standard errors19 and can illu-
minate associations between the outcomes and critical
background characteristics. Thus, baseline measures of out-
come variables were included in the regression equations,
since these are highly likely to be correlated to reports at
TABLE 3. Results of multivariate analyses examining associations between female condom use outcomes and selected
predictors
Outcome Intervention Couples (vs. Baseline  Male HIV-positive (vs. HIV status 
(vs. control) women-only) measurement HIV-negative) unknown (vs. 
of outcome HIV-negative)
Ever used in past 90 days†
With study partner 4.06* 1.13 10.67** 1.17 0.98 1.25 
(1.24–13.35) (0.44–2.91) (2.34–48.71) (0.58–2.38) (0.40–2.44) (0.33–4.67)
With all partners 3.57* 1.03 6.06* 1.27 0.93 1.97 
(1.11–11.54) (0.40–2.66) (1.21–30.35) (0.64–2.51) (0.35–2.45) (0.60–6.41)
No. of uses in past 90 days‡
With study partner 4.33* 1.38 2.33 1.10 0.98 1.18 
(1.38–13.58) (0.55–3.45) (0.92–5.91) (0.56–2.17) (0.40–2.36) (0.37–3.81)
With all partners 3.73* 1.39 1.70 0.97 0.90 1.81 
(1.32–10.54) (0.53–3.65) (0.73–3.96) (0.43–2.22) (0.37–2.20) (0.66–5.00)
Intend to use in next 90 days† 2.20* 1.16 2.61** 1.18 1.21 1.07 
(1.12–4.32) (0.61–2.20) (1.48–4.59) (0.74–1.88) (0.61–2.39) (0.48–2.37)
Outcome expectancies§ 1.76 0.79 0.44** 0.07 –0.42 –2.14 
(–0.28 to 3.80) (–1.40 to 2.99) (0.32–0.57) (–1.67 to 1.81) (–2.70  to 1.85) (–5.13 to 0.85)
*p<.05. **p<.01. †Odds ratios from logistic regression. ‡Incidence rate ratios from negative binomial regression. §Coefficients from ordinary least squares regression.
Notes: All models include random effects estimates. Figures in parentheses are 95% confidence intervals.
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ing follow-up than participants in the control group. Par-
ticipants in the couples and women-only groups demon-
strated a larger percentage change in intentions to use the
device from baseline to follow-up than participants in the
control group.
Consistent with the bivariate results, findings from the
regression analyses show significantly different outcomes
for participants assigned to the intervention groups and
controls (Table 3, page 151). Compared with the controls,
participants in either active intervention group were more
likely to have used a female condom with their study part-
ner and with all partners combined during follow-up (odds
ratios, 4.1 and 3.6, respectively), used female condoms at
higher rates with their study partners and with all partners
during follow-up (incidence rate ratios, 4.3 and 3.7, re-
spectively) and were more likely to intend to use the con-
dom in the next 90 days (odds ratio, 2.2). However, there
was no statistical difference in female condom use outcome
expectancies. There were no significant differences between
the women-only and couples intervention groups. 
As expected, the baseline measures were significantly
associated with their corresponding outcome measures at
follow-up for almost all variables of interest. (The only ex-
ception is the number of times a female condom was used.)
Gender and HIV status were not significantly associated
with any outcome. 
DISCUSSION
This study is the first clinical trial to demonstrate the effi-
cacy of a relationship-based intervention at promoting fe-
male condom use among long-term heterosexual couples,
and to test competing strategies for introducing the device.
Our findings demonstrate that focusing on both a woman
and her male partner is efficacious in increasing female con-
dom use and intention to use among heterosexual couples
at risk for HIV and other STDs. The findings for the women-
only group are consistent with results of other female con-
dom intervention trials targeting women individually.21 The
findings that both active interventions increased female con-
dom use and use intentions add to the literature by offer-
ing two efficacious methods for promoting the device, one
of which incorporates a woman’s main male sexual partner. 
Consistent with the principal outcomes of the parent
study,22 the results of this study demonstrated no signifi-
cant differences in outcomes between participants in the
couples group and participants in the women-only group.
We offer several possible explanations for these findings.
First, all active intervention content was identical, with both
groups focusing on the intimate relationship. Even in women-
only sessions, the relationship, and compromise between
partners in risk reduction activities, was emphasized. Prac-
ticing communication, negotiation and condom skills aimed
at cooperative risk reduction to strengthen the relationship,
even without the partner present, may have been the key to
the success of the intervention. A second potential factor is
self-selection: Recruitment of females, who then recruited
male partners, may have biased the sample toward includ-
ing females who are comfortable discussing STD preven-
tive behaviors with their partners and toward male partners
who are highly motivated to engage in such behaviors and
to use female condoms. Third, attendance was higher in the
women-only group than in the couples group, and additional
exposure may have facilitated greater improvement with re-
spect to sexual risk behavior. Finally, the intervention pro-
moted use of a hierarchy of risk reduction strategies, in which
women and couples may adopt alternative strategies to male
or female condom use.23 One suggested alternative was “ne-
gotiated safety,” the option of agreeing to mutual monogamy
or to use of barrier protection with casual partners only, fol-
lowing HIV testing.24 A purer test of outcome differences
would have included an intervention that offered only the
choice of male or female condoms, or perhaps female con-
doms alone, rather than a safer-sex hierarchy. Future research
on strategies for introducing the female condom needs to
consider ways to more carefully control for alternative
method choices. 
The increase in ever-use of a female condom from base-
line to follow-up suggests that there were many first-time
users among participants. This is consistent with findings
of other studies and suggests a subsample of potential fe-
male condom adopters,25 who should be of particular in-
terest in future research. Although Musaba et al.26 found
that on average, among participants counseled to use ei-
ther male or female condoms, female condoms were used
in 24%, 27% and 23% of coital acts during three-, six- and
12-month follow-up, most longitudinal studies indicate that
adopters of the female condom may use the device only
for a short time, or use it with decreasing frequency over
time.27 Further research is needed to identify these female
condom adopters, to more effectively target those women
and men who may be most receptive to using this method.
Additional research to identify effective strategies to pro-
mote adoption and long-term use among couples is also
needed.
The finding that participants in both active groups re-
ported a relatively high intention to use the device within
the next 90 days carries important implications. This find-
ing is consistent with earlier ones suggesting that having
an opportunity to become familiar with and use the device
may facilitate more comfort with it and enhance intentions
for use.28 Despite poor response to the device in the gen-
eral press over the past decade,29 its introduction to cou-
ples, at least among our sample, is still being met with en-
thusiasm, interest and intention to use. Researchers may
need to examine additional external factors, including avail-
ability and accessibility, as potential barriers to initiation
and sustained use of the device.
Artz and colleagues30 found that among women in STD
clinics who received a skill-based introduction to the female
condom with take-home materials (including a motivational
video to show their male partners), 79% tried the device
at least once. In the present study, the control group watched
a video on female condom insertion and received some ed-
ucation about the device, but the outcome effects were sig-
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Health, 2004, 13(10):1137–1147.
11. Straus MA et al., The Revised Conflict Tactics Scales (CTS2): de-
velopment and preliminary psychometric data, Journal of Family Issues,
1996, 17(3):283–316.
12. Witte SS et al., 2004, op. cit. (see reference 10).
13. New York City Department of Health and Mental Hygiene, For
Women Only: What Women Can Do to Protect Themselves from AIDS,
Albany, NY: New York State Department of Health, 1997.
14. Witte SS et al., 2000, op. cit. (see reference 5).
15. Schafer JL, Analysis of Incomplete Multivariate Data, London:
Chapman & Hall, 1997; and Rubin DB, Multiple Imputation for
Nonresponse in Surveys, New York: John Wiley & Sons, 1987.
16. Royston P, Multiple imputation of missing values: update, Stata
Journal, 2005, 5(2):118–201.
17. Gardner W, Mulvey EP and Shaw EC, Regression analyses of counts
and rates: Poisson, overdispersed Poisson, and negative binomial mod-
els, Psychological Bulletin, 1995, 118(3):392–404.
18. Koepsell TD et al., Data analysis and sample size issues in evalua-
tions of community-based health promotion and disease prevention
programs: a mixed-model analysis of variance approach, Journal of
Clinical Epidemiology, 1991, 44(7):701–713; and Zhou H and Weinberg
CR, Potential for bias in estimating human fecundability parameters:
a comparison of statistical models, Statistics in Medicine, 1999,
18(4):411–422.
nificantly greater in the active intervention groups. More
research is needed to determine if outcomes are improved
when those receiving individualized health education are
given motivational or educational videotapes of female con-
dom demonstrations to share with their partners.
Our findings must be considered in light of the follow-
ing limitations. The study had a relatively small sample, data
were self-reported and did not include biological outcomes
on STDs, and the follow-up period was short. (We con-
ducted a 12-month follow-up with the women, but were
unable to do so for their male partners because of funding
limitations.) The 90-day recall period, although standard
for STD clinical trials, may have challenged the participants’
ability to respond accurately. Study designs incorporating
longer follow-up periods with larger samples and shorter
recall periods, may produce stronger findings regarding
promotion of female condom use among couples. The fe-
males in this study recruited their male partners, which may
have led to a sample of self-selected male partners. Also,
participants in the control group were not given free female
condoms, as the active intervention participants were, but
rather were advised about where they could them obtain
for free. Because the mean number of female condoms used
by participants was small, findings may have been influ-
enced by participants’ access to the method. However, al-
though active intervention participants could have received
up to 18 female condoms by attending all six sessions, these
condoms may well have been used prior to the 90-day 
follow-up phase, upon which the data are based. Further,
nonsignificant mean increases in female condom use re-
ported by controls suggest that this group did access fe-
male condoms. Future designs must equalize both the num-
ber of devices and the time frame for which devices are made
available to participants across groups. Outside of clinical
trials, limited accessibility and availability of female con-
doms remains a significant barrier to use and uptake. 
Until safe, efficacious and approved microbicides are
widely available as an STD risk reduction method for
women and their male partners, the female condom is a
critical method, of empirically demonstrated effectiveness,
and should be more widely promoted. Couple-based ap-
proaches, and increased opportunities to involve male part-
ners in device use, should continue to be explored. Efforts
must continue to develop innovative female condom pro-
motion strategies and test them in rigorous trial designs.
Research should target not only how best to  introduce the
device to individual women, men and couples, but how best
to promote sustained use of the device. Although lack of
availability and accessibility of the female condom are dif-
ferent issues from individual promotion strategies,31 si-
multaneous efforts must be made to increase availability
and accessibility as a key to sustained use of the device.
REFERENCES
1. Ehrhardt AA and Exner TM, Prevention of sexual risk behavior for
HIV infection with women, AIDS, 2000, 14(Suppl. 2):S53–S58; El-Bassel
N et al., HIV prevention for intimate couples: a relationship-based model,
Families, Systems and Health, 2001, 19(4):379–395; and Musaba E et
154 Perspectives on Sexual and Reproductive Health
19. Cochran WG and Cox GM, Experimental Designs, second ed., New
York: John Wiley & Sons, 1992.
20. Voluntary HIV-1 Counseling and Testing Efficacy Study Group,
Efficacy of voluntary HIV-1 counselling and testing in individuals and
couples in Kenya, Tanzania, and Trinidad: a randomised trial, Lancet,
2000, 356(9224):103–112; Dolezal C et al., Sexual risk behavior changes
among HIV+ and HIV- female injecting drug users over 4 years, Women
& Health, 1998, 27(4):1–17; and Dolezal C et al., Longitudinal changes
in sexual risk behavior among HIV+ and HIV- male injecting drug users,
American Journal of Drug and Alcohol Abuse, 1999, 25(2):281–303.
21. Hoffman S et al., 2003, op. cit. (see reference 5); Kalichman SC,
Williams E and Nachimson D, Brief behavioral skills building inter-
vention for female controlled methods of STD-HIV prevention: out-
comes of a randomized clinical field trial, International Journal of STD
& AIDS, 1999, 10(3):174–181; and Van Devanter N et al., Effect of an
STD/HIV behavioral intervention on women’s use of the female con-
dom, American Journal of Public Health, 2002, 92(1):109–115.
22. El-Bassel N et al., 2005, op. cit. (see reference 9); and El-Bassel N
et al., 2003, op. cit. (see reference 9).
23. Gollub EL et al., A randomized trial of hierarchical counseling in a
short, clinic-based intervention to reduce the risk of sexually transmitted
diseases in women, AIDS and Behavior, 2000, 14(9):1249–1255; Latka
M et al., Male-condom and female-condom use among women after
counseling in a risk-reduction hierarchy for STD prevention, Sexually
Transmitted Diseases, 2000, 27(8):431–437; and Stein Z et al., 1999, op.
cit. (see reference 5).
24. O’Leary A, Preventing HIV infection in heterosexual women: what
do we know? what must we learn? Applied and Preventive Psychology,
1999, 8(4):257–263.
25. Musaba E et al., 1998, op. cit. (see reference 1); Artz L et al., 2000,
op. cit. (see reference 5); Gollub EL et al., 2000, op. cit. (see reference
23); Kalichman SC, Williams E and Nachimson D, 1999, op. cit. (see
reference 21); Stein Z et al., 1999, op. cit. (see reference 5); and Sly DF
et al., Factors associated with the use of the female condom, Family
Planning Perspectives, 1997, 29(4):181–184.
26. Musaba E et al., 1998, op. cit. (see reference 1).
27. Ibid.; Hoffman S et al., 2003, op. cit. (see reference 5); and Padian
N et al., Choice of female-controlled methods in Northern California,
paper presented at the 127th meeting of the American Public Health
Association, Chicago, Nov. 7–11, 1999.
28. Cecil H et al., 1998, op. cit. (see reference 2); Artz L et al., 2000, op.
cit. (see reference 5); Kalichman SC, Williams E and Nachimson D, 1999,
op. cit. (see reference 21); Witte SS et al., Acceptability of the female
condom among women exchanging street sex in New York City,
International Journal of STD & AIDS, 1999, 10(3):162–168; El-Bassel N
et al., Correlates of intention to use the female condom among women
on methadone, Women’s Health Issues, 1998, 8(2):112–122; and Gollub
EL, Stein Z and El-Sadr W, Short-term acceptability of the female con-
dom among staff and patients at a New York City hospital, Family
Planning Perspectives, 1995, 27(4):155–158.
29. Kaler A, The female condom in North America: selling the tech-
nology of empowerment, Journal of Gender Studies, 2004, 13(2):139–152.
30. Artz L et al., 2000, op. cit. (see reference 5).
31. Hoffman S et al., 2004, op. cit. (see reference 2); and French PP et
al., 2003 op. cit. (see reference 3).
Acknowledgment
This study was supported by National Institute of Mental Health
grant MH57145.
Author contact: ssw12@columbia.edu
Promoting Female Condom Use to Heterosexual Couples
